Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …

Human respiratory virus infections lead to a spectrum of respiratory symptoms and disease
severity, contributing to substantial morbidity, mortality and economic losses worldwide, as …

This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …

Prospective cohorts of 3,950 health care personnel, first responders, and other essential and
frontline workers completed weekly SARS-CoV-2 testing for 13 consecutive weeks. Under …

Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

One year into the global COVID-19 pandemic, the focus of attention has shifted to the
emergence and spread of SARS-CoV-2 variants of concern (VOCs). After nearly a year of …

Key Clinical Points Rapid Diagnostic Testing for SARS-CoV-2 Rapid diagnostic tests (RDTs)
that are authorized by the Food and Drug Administration to diagnose severe acute …

The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …

Background Spain is one of the European countries most affected by the COVID-19
pandemic. Serological surveys are a valuable tool to assess the extent of the epidemic …

This document is an update to the scientific brief published on 29 March 2020 entitled
“Modes of transmission of virus causing COVID-19: implications for infection prevention and …